No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia

Endocrine-Related Cancer

Volumn 14, Issue 3, 2007, Pages 901-906

  Raitila, A ^a   Georgitsi, M ^a   Karhu, A ^a   Tuppurainen, K ^b   Makinen M J ^b   Birkenkamp Demtroder K ^c   Salmenkivi, K ^a   Orntoft T F ^c   Arola, J ^a   Launonen, V ^a   Vahteristo, P ^a   Aaltonen, L A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; AROMATIC HYDROCARBON RECEPTOR INTERACTING PROTEIN; PROLACTIN; PROTEIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; ENDOCRINE TUMOR; FEMALE; FINLAND; FOUNDER EFFECT; GENE SEQUENCE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PROLACTINOMA; SOMATIC MUTATION; WILD TYPE;

ADENOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; CARCINOMA; DNA MUTATIONAL ANALYSIS; ENDOCRINE GLAND NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; PROTEINS;

EID: 35948953263     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/ERC-07-0025     Document Type: Article

References (22)

1. Arafah BM & Nasrallah MP 2001 Pituitary tumors: pathophysiology, clinical manifestations and management. Endocrine-Related Cancer 8 287-305.
2. Barlier A, Vanbellinghen JF, Daly AF, Silvy M, Jaffrain-Rea ML, Trouillas J, Tamagno G, Cazabat L, Bours V, Brue T, et al. 2007 Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 92 1952-1955.
3. Boikos SA & Stratakis CA 2006 Carney complex: pathology and molecular genetics. Neuroendocrinology 83 189-199.
4. Casey M, Vaughan CJ, He J, Hatcher CJ, Winter JM, Weremowicz S, Montgomery K, Kucherlapati R, Morton CC & Basson CT 2000 Mutations in the protein kinase A Rl alpha regulatory subunit cause familial cardiac myxomas and Carney complex. Journal of Clinical Investigation 106 R31-R38.
5. Chandrasekharappa SC, Guru SC, Manickam P, Olufemi SE, Collins FS, Emmert-Buck MR, Debelenko LV, Zhuang Z, Lubensky IA, Liotta LA et al. 1997 Positional cloning of the gene for multiple endocrine neoplasia-type 1. Science 276 404-407.
6. Daly AF, Vanbellinghen JF, Khoo SK, Jaffrain-Rea ML, Naves LA, Guitelman MA, Murat A, Emy P, Gimenez-Roqueplo AP, Tamburrano G et al. 2007 Aryl hydrocarbon receptor interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families. Journal of Clinical Endocrinology and Metabolism 92 1891-1896.
7. Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, Launonen V & Aaltonen LA 2007a Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers. British Journal of Cancer 96 352-356.
8. Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Mäkinen MJ, Vierimaa O, Paschke R, Saeger W, van der Luijt RB, Sane T et al. 2007b Molecular diagnosis of pituitary adenoma predisposition, caused by aryl hydrocarbon receptor interacting protein gene mutations. PNAS 104 4101-4105.
9. Iwata T, Yamada S, Mizusawa N, Golam HMD, Sano T & Yoshimoto K 2007 The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas. Clinical Endocrinology 66 499-502.
10. Kaltsas GA, Besser GM & Grossman AB 2004 The diagnosis and medical management of advanced neuroendocrine tumors. Endocrine Reviews 25 458-511.
11. Kauppinen-Makelin R, Sane T, Reunanen A, Valimaki MJ, Niskanen L, Markkanen H, Loyttyniemi E, Ebeling T, Jaatinen P, Laine H et al. 2005 A nationwide survey of mortality in acromegaly. Journal of Clinical Endocrinology and Metabolism 90 4081-4086.
12. Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF et al. 1999 Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 18 4643-4646.
13. Kirschner LS, Carney JA, Pack SD, Taymans SE, Giatzakis C, Cho YS, Cho-Chung YS & Stratakis CA 2000 Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex. Nature Genetics 26 89-92.
14. Lemmens I, Van de Ven WJ, Kas K, Zhang CX, Giraud S, Wautot V, Buisson N, De Witte K, Salandre J, Lenoir G et al. 1997 Identification of the multiple endocrine neoplasia type 1 (MEN1) gene. The European Consortium on MEN1. Human Molecular Genetics 6 1177-1183.
15. Leotlela PD, Jauch A, Holtgreve-Grez H & Thakker RV 2003 Genetics of neuroendocrine and carcinoid tumours. Endocrine-Related Cancer 10 437-450.
16. Spada A, Mantovani G & Lania A 2005 Pathogenesis of prolactinomas. Pituitary 8 7-15.
17. Stratakis CA, Kirschner LS & Carney JA 2001 Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation. Journal of Clinical Endocrinology and Metabolism 86 4041-4046.
18. Thakker RV 1998 Multiple endocrine neoplasia-syndromes of the twentieth century. Journal of Clinical Endocrinology and Metabolism 83 2617-2620.
19. Toledo RA, Lourenco DM Jr, Liberman B, Cunha-Neto MB, Cavalcanti MG, Moyses CB, Toledo SP & Dahia PL 2007 Germline mutation in the Aryl hydrocarbon receptor interacting protein (AIP) gene in familial somatotropinoma. Journal of Clinical Endocrinology and Metabolism 92 1934-1937.
20. Vierimaa O, Georgitsi M, Lehtonen R, Vahteristo P, Kokko A, Raitila A, Tuppurainen K, Ebeling TM, Salmela PI, Paschke R et al. 2006 Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312 1228-1230.
21. Yang Q, Yoshimura G, Nakamura M, Nakamura Y, Suzuma T, Umemura T, Mori I, Sakurai T & Kakudo K 2002 BRCA1 in non-inherited breast carcinomas (Review). Oncology Reports 9 1329-1333.
22. Yu R, Bonert V, Saporta I, Raffel LJ & Melmed S 2006 Aryl hydrocarbon receptor interacting protein variants in sporadic pituitary adenomas. Journal of Clinical Endocrinology and Metabolism 91 5126-5129.